Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as prognostic factors in rheumatoid arthritis: results from the ESPOIR cohort

Fig. 2

Receiver operating characteristic (ROC) curve to determine the best threshold for OPG/TRAIL ratio to predict rapid erosions. Patients treated with biological therapy during the first 2 years and with radiographic evidence of damage at baseline were excluded. Osteoprotegerin to tumor necrosis factor-related apoptosis-inducing ligand (OPG/TRAIL) ratio (both values expressed in pg/ml). The star shows the 1.198 OPG/TRAIL ratio

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us